Resistance to antimicrobial drugs in Enterococcus sp strains isolated in hospitals of Northern Chile;Resistencia a antimicrobianos en cepas de Enterococcus sp aisladas en hospitales del Norte de Chile

Revista Chilena de Infectologia

Volumn 23, Issue 3, 2006, Pages 226-231

  Silva A , Juan ^a   Asserella R , Leyla ^a   Bolados G , Nury ^a   Herrera H , Nelson ^a   Leyton O , Johanna ^a  

^a UNIVERSIDAD DE ANTOFAGASTA   (Chile)

Author keywords

Enterococcus spp; Multiresistance; Nosocomial infections; Resistance

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CHILE; CLASSIFICATION; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; CHILE; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 33749014154     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Murray B E. Vancomycin-resistant enterococci. Am J Med 1997; 102: 284-93.
2. Moellering R C Jr. The enterococci: an enigma and a continuing therapeutic challenge. Eur J Clin Microbiol Infect Dis 1990; 9: 73-4.
3. Spera R V, Farber B F. Multidrug-resistant Enterococcus faecium. An intreatable nosocomial pathogen. Drug 1994; 48: 678-88.
4. Linden P K, Millar C B. Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. Diagn Microbiol Infect Dis 1993; 33: 113-20.
5. Shepard B D, Gilmore M S. Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. Microbes Infect 2002; 4: 215-24.
6. Palavecino E. Puesta al día en enterococos-año 2001. Identificación de especies y estudio de susceptibilidad antimicrobiana. Rev Chil Infect 2001; 18: 95-100.
7. Juliet C. Estudio de susceptibilidad in vitro de Enterococcus spp. Rev Chil Infect 2002; 19: 111-5.
8. Murray B E. Diversity among multidrug-resistant enterococci. Emerg Infect Dis 1998; 4: 37-47.
9. Bonten M J M, Hayden M K, Nathan C, van Voorhis J, Matushek M, Slaughter S, et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348: 1615-9.
10. Kjerulf A, Pallesen L, Westh H. Vancomycin-resistant enterococci at a large university hospital in Dermarck. APMIS 1996; 104: 475-9.
11. Häallgren A, Abednazari H, Ekdahl C, Hanberger H, Nilsson M, Samuelsson A, et al. Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. J Antimicrob Chemother 2001; 48: 53-62.
12. Scanelli M, Pellizer G, de Halla F, D'Emilio A, Rassu M, Bragagnolo L, et al. Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in Northern Italy. Eur J Clin Microbiol Infect Dis 2001; 20: 609-16.
13. Pegues D A, Pegues C F, Hibberd P L, Ford D S, Hooper D C. Emergence and dissemination of a highly resistant van A strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997; 35: 1565-70.
14. Rice L B. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 2001; 7: 183-7.
15. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23: 1020-5.
16. Martone W J. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998; 19: 539-45.
17. Puzniak L A, Mayfield J, Leet T, Kollef M, Mundy LM. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis 2001; 33: 151-7.
18. Rice L B, Hutton-Thomas R, Lakticova V, Helfand M S, Donskey C J. β-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis 2004; 189: 1113-8.
19. Kühn I, Iversen A, Burman L G, Olsson-Liljequist B, Franklin A, Finn M, et al. Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Int J Antimicrob Agents 2000; 14: 337-42.
20. Wegener H C. Antibiotics in animal feed and their role in resistance development. Curr Opin Microbiol 2003; 6: 439-45.
21. Iversen A, Kuhn I, Franklin A y Möllby R. High prevalence of vancomycin resistant enterococci in Swedish sewage. J Clin Microbiol 2002; 68: 2838-42.
22. Abarca J A, Donalds L C, Pinto M E, Palavecino E, González P, Cona E, et al. Profiency in detecting vancomycin resistance in enterococci among clinical laboratories in Santiago, Chile. Emerg Infect Dis 2001; 5: 839-40.
23. Cookson S T, Lopardo H, Marín M, Arduino R, Rial M J, Altschuler M, et al. Study to determine the ability of clinical laboratories to detect antimicrobial-resistant Enterococcus spp in Buenos Aires, Argentina. Diagn Microbiol Infect Dis 1997; 29: 107-9.
24. McDonalds L C, Garza L R, Jarvis W R. Proficency of clinical laboratories in Spain in detecting vancomycin-resistant Enterococcus. Emerg Infect Dis 1999; 5: 143-6.
25. Alonso-Echanove J, Robles B, Jarvis W R. Proficiency of clinical laboratories in Spain in determining vancomycin-resistant Enterococcus spp. The Spanish VRE Study Group. J Clin Microbiol 1999; 37: 2148-52.
26. Jones M E, Gesu G, Ortisi G, Sahm D F, Critchley I A, Goglio A, et al. Glycopeptide susceptibility in Enterococcus and Staphylococcus spp using routine laboratory methodologies. Clin Microbiol Infect 2002; 8: 101-11.
27. Tenover F C, Tokar F C, Swenson J, Spitalny K, Jarvis W. Ability of clinical laboratories to detect antimicrobial resistant enterococci. J Clin Microbiol 1993; 31: 1695-9.
28. Marín M E, Mera J R, Arduino R C, Correa A P, Coque T M, Stamboulian D, et al. First report of vancomycin resistant Enterococcus faecium isolated in Argentine. Clin Infect Dis 1998; 26: 235-6.
29. Dalla-Costa L M, Souza D C, Martins L T, Zanella R C, Brandilone M C, Bokermann S, et al. Vancomycin-resistant Enterococcus faecium: first case in Brazil. Braz J Infect Dis 1998; 2: 160-3.
30. Marovac J, Campos M I. Enterococcus faecium resistente a vancomicina. Rev Méd Chile 2000; 128: 685-6.
31. Donabediam S M, Thal L A, Hershberger R, Perri M B, Chow J W, Bartlett P, et al. Molecular characterization of gentamicin-resistant enterococci in the United States: evidence of spread from animals to humans through food. J Clin Microbiol 2003; 41: 1109-13.
32. Chow J W. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 2000; 31: 586-9.
33. Tsai S F, Zervos M J, Clewell D B, Donabediam S M, Sahm D F, Chow J W. A new-level gentamicin resistance gene, aph(2″)-Id, in Enterococcus spp. Antimicrob Agents Chemother 1998; 42: 1229-32.
34. Giglio M, Pinto M, Córdova E, Escandar P, Waman C. Identificación de especies de Enterococcus en muestras clínicas y susceptibilidad a agentes antimicrobianos. Rev Méd Chile 1996; 124: 70-6.
35. Manero A, Blanch A. Identification of Enterococcus spp with a biochemical key. Appl Environ Microbiol 1999; 65: 4425-30.
36. NCCLS. Performance standards for antimicrobial susceptibility testing. Eleventh Informational Supplement NCCLS Document M100-SII. National Committee for Clinical Laboratory Standard. Wayne, Pa. 2001
37. Murray B E, Singh K V, Markowitz S M, Lopardo H A, Patterson J E, Zervos M J, et al. Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis 1991; 163: 780-5.
38. Vigilancia de Enterococcus spp 2001. www.ispch.cl. (accedido 03/10/2003)
39. Iversen A, Kuhn I, Rahman M, Franklin A, Burman L G, Olsson-Liljequist B, et al. Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium. Environ Microbiol 2004; 6: 55-9.
40. Onodera Y, Okuda J, Tanaka M, Sato K. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46: 1800-4.
41. del Campo R, Tenorio C, Rubio C, Castillo J, Torres C, Gómez-Lus R. Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp in Spain. Int J Antimicrob Agents 2000; 15: 221-6.
42. Rodríguez Y, Silva J, Araya J, Kühn I, Colque-Navarro P, Möllby R. Caracterización de la resistencia a aminoglicósidos de cepas clínicas y ambientales de enterococos aisladas en Antofagasta. Acta Microbiol 2004; 10: 129.